As attention to vaccine liability heats up, the justices of the U.S. Supreme Court are weighing whether to hear a case from Georgia in which the state high court has said vaccine makers could be held liable for a boy’s neurological problems.
In an unusual turn, the Georgia plaintiffs have dropped their suit for now, meaning that a similar case from Pennsylvania could be the vehicle by which the nation’s highest court decides the question.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
